Jong Hoon Lee (Jong-Hoon Lee)

Years Active: 2020-2022
Publications (10 Years): 5

Seoul National University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Seoul National University Mar 01 1989 - Feb 28 1996

South Korea

PHD :: College of medicine

Publications

Badar A Kanwar, Asif Khattak, Jenny Balentine, Jong Hoon Lee, Richard Eric Kast
Benefits of Using Dapsone in Patients Hospitalized with COVID-19. Vaccines 10 (2) (2022)
Jong Hoon Lee, Badar A Kanwar, Asif Khattak, Jenny Balentine, Ngoc Huy Nguyen, Richard Eric Kast, Chul Joong Lee, Jean Bourbeau, Eric L Altschuler, Consolato Maria Sergi, Tuan Ngoc Minh Nguyen, Sangsuk Oh, Mun-Gi Sohn, Michael D Coleman
COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs. International journal of molecular sciences 23 (21) (2022)
Jong Hoon Lee
The listed, delisted, and sustainability of therapeutic medicines for dementia patients: the study is specific to South Korea. Naunyn-Schmiedeberg's archives of pharmacology 395 (5) (2022)
Badar Kanwar, Chul Joong Lee, Jong Hoon Lee
Specific Treatment Exists for SARS-CoV-2 ARDS. Vaccines 9 (6) (2021)
Jong Hoon Lee, Ha Kyeu An, Mun-Gi Sohn, Paul Kivela, Sangsuk Oh
4,4'-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor. International journal of molecular sciences 21 (17) (2020)

Jong Hoon Lee.css-eqlu8i{font-size:small;padding-left:4px;} (Jong-Hoon Lee)